Axsome Therapeutics Inc. (19X)
XSTU
Real-time Data
06:00 AM
Day's Range
153.8052 wk Range
101.20Overview - 19X - Axsome Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
7.87B
P/E (Trailing)
‪-46.29‬
Price / Sales (TTM)
‪12.50‬
EV / EBITDA
‪-49.18‬
Profitability
Gross Margin
‪93.78%‬
Profit Margin
‪92.56%‬
Operating Margin
‪-27.74%‬
Return on Assets
‪-26.55%‬
Return on Equity
‪-207.45%‬
Ownership
Shares Outstanding
52.29M
Price stats
50-Day Avg
‪139.47‬
200-Day Avg
‪110.06‬
Market Cap - 19X - Axsome Therapeutics Inc.
Peers - 19X - Axsome Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 19XXSTUAxsome Therapeutics Inc.7.98BMarket Cap+41.36%52-week change-46.29P/E (Trailing)‪92.56%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+6.26%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech, Inc.8.99BMarket Cap+52.99%52-week change43.02P/E (Trailing)‪54.81%‬Profit Margin
- 2X10XSTUAbivax SA Sponsored ADR7.19BMarket Cap+12.50%52-week change-16.56P/E (Trailing)‪0.00%‬Profit Margin
- 30JXSTUIDEAYA Biosciences Inc.3.10BMarket Cap+29.17%52-week change-25.15P/E (Trailing)‪-74.75%‬Profit Margin
- BSFAXSTUAni Pharmaceuticals, Inc.1.49BMarket Cap-19.23%52-week change16.21P/E (Trailing)‪11.07%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+55.76%52-week change-96.80P/E (Trailing)—Profit Margin
Profile Summary - 19X - Axsome Therapeutics Inc.
About
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its marketed products include Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness related to narcolepsy or obstructive sleep apnea, and Symbravo…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
